Valuation Indivior Pharmaceuticals, Inc. London S.E.

Stocks

Market Closed - London S.E. 16:35:04 24/07/2025 BST			5-day change	1st Jan Change
1,238.00 ^GBX	+1.56%		+5.27%	+20.90%

08-03	Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility	CI
08-03	Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,115	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	-8.14%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	4,103	3,545	2,924
Change	-	55.81%	-17.52%	-21.95%	193.72%	-10.89%	-13.59%	-17.51%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	9.37x	8.49x	7.77x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0x	0.8x	0.83x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.09x	2.94x	2.76x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	3.08x	2.53x	1.96x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	5.63x	4.48x	3.4x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	5.96x	4.81x	3.68x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	8.06x	6.52x	4.73x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	12.4%	15.3%	21.1%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.72	4.105	4.49
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,332	1,400	1,489
EBITDA ¹	202	225	288	338	428	728.4	790.8	859.6
EBIT ¹	187	212	269	312	415	688.8	737.7	795.7
Net income ¹	205	-53	2	-48	210	474.3	530	582.9
Net Debt ¹	-860	-534	-77	14	124	-12.5	-570	-1,191
Reference price ²	17.25	21.75	15.27	12.43	35.88	34.87	34.87	34.87
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	118,014	-	-
Announcement Date	16/02/22	16/02/23	22/02/24	20/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.44x	12.14x	24.6x	0.59%	1,047B
JOHNSON & JOHNSON	29.82x	-	-	2%	646B
ABBVIE INC.	32.61x	7.57x	15.74x	2.68%	451B
ROCHE HOLDING AG	19.99x	4.75x	11.76x	2.79%	355B
NOVARTIS AG	21.76x	5.62x	13.93x	2.85%	291B
ASTRAZENECA PLC	20.88x	4.29x	12.24x	2.06%	252B
AMGEN INC.	27.35x	7.07x	12.56x	2.33%	234B
NOVO NORDISK A/S	13.25x	4.77x	9.95x	3.83%	203B
GILEAD SCIENCES, INC.	-44.51x	6.43x	25.11x	2.26%	181B
Average	17.17x	6.58x	15.74x	2.38%	406.59B
Weighted average by Cap.	24.24x	8.07x	17.81x	1.97%